JP4106430B2 - Protective agent for biological damage caused by ionizing radiation and protection method using the same - Google Patents

Protective agent for biological damage caused by ionizing radiation and protection method using the same Download PDF

Info

Publication number
JP4106430B2
JP4106430B2 JP2001284016A JP2001284016A JP4106430B2 JP 4106430 B2 JP4106430 B2 JP 4106430B2 JP 2001284016 A JP2001284016 A JP 2001284016A JP 2001284016 A JP2001284016 A JP 2001284016A JP 4106430 B2 JP4106430 B2 JP 4106430B2
Authority
JP
Japan
Prior art keywords
ionizing radiation
beer
protective agent
damage caused
biological damage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2001284016A
Other languages
Japanese (ja)
Other versions
JP2003089634A (en
Inventor
興一 安藤
真奈美 物部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Radiological Sciences
Original Assignee
National Institute of Radiological Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute of Radiological Sciences filed Critical National Institute of Radiological Sciences
Priority to JP2001284016A priority Critical patent/JP4106430B2/en
Publication of JP2003089634A publication Critical patent/JP2003089634A/en
Application granted granted Critical
Publication of JP4106430B2 publication Critical patent/JP4106430B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【0001】
【発明の属する技術分野】
この出願の発明は、X線やγ線、粒子線等の電離放射線による生物障害の防護剤とこれを用いた防護方法に関するものである。
【0002】
【従来の技術と発明の課題】
電離放射線に被曝した場合に遺伝子障害あるいは致死などの生物障害が現れることが知られており、このような生物障害作用を防護するための方法がこれまでにも様々な観点より検討されている。
【0003】
たとえば、具体的にも、電離放射線の生物障害作用の防護に関しては、これまでにも、鉛による防護や薬剤による防護方法が知られている。そこで、放射線の細胞障害はラジカル反応による間接作用がその約75%を占めると考えられていることから、これまでの放射線障害防護剤はラジカルスカベンジャーが主な防護剤であった。しかしながら、現在までに多くのラジカルスカベンジャーが放射線障害防護剤として検討されているが、実用的薬剤とはなっておらず、安全性や有効性の面で問題があるとされている。また近年航空機や宇宙進出により直接作用が主体の放射線に対する防護が重要となってきたが、直接作用の強い放射線に対する防護剤は副作用の強いものが多く、人に直接に適応でき生命に安全な方法はないに等しく、外部被曝や内部被曝を少なくするよう努力する以外に防護する方法がないのが実情であった。すなわち、人に対して直接適応することのできる安全な方策はなかった。
【0004】
この出願の発明は以上のとおりの事情に鑑みてなされたものであって、安全性が高く、しかも簡便であって、比較的長い時間電離放射線の生物障害を防護することができ、かつ人に対しても適用することのできる新しい技術手段を提供することを課題としている。
【0005】
【課題を解決するための手段】
この出願の発明は、上記のとおりの課題を解決するものとして、ビールを有効成分とすることを特徴とする炭素イオン線による生物障害の防護剤を提供する。
【0008】
【発明の実施の形態】
この出願の発明は、上記のとおりの特徴をもつものであるが、以下に、その実施の形態について説明する。
【0009】
なによりもこの出願の発明において特徴的なことは、電離放射線による生物障害を、アルコール性飲料を有効成分とする防護剤によって極めて効果的に防護することである。
【0010】
有効成分としてのアルコール飲料は、これまでによく知られているものをはじめ、醸造酒、蒸留酒、そして混成酒のいずれかであってよく、市販品をはじめ、各種のものでよい。これらのアルコール飲料は、例えば市販品として直接に、あるいはこれを水や生理食塩水等によって希釈して、さらには、糖分を加えたり、各種のフレーバーを加えたり、栄養分、さらには他の薬剤を加えたりしたものとして、防護剤を構成することができる。
【0011】
なかでも、この出願の発明においてより効果的な防護剤は、麦芽または麹によって糖化させた成分を含有するアルコール飲料である。とりわけ、ビール成分を含有したものが効果的なものの一つとして例示される。
【0012】
有効成分としてのアルコール飲料におけるアルコール(エタノール)の含有割合は2〜15%程度のものが好ましい。
実際の使用に際しては、経口投与することができ、対象者の体質や電離放射線による被曝環境、そして防護が必要とされる時間等に応じて、その使用量を調整することができる。もちろん、防護の対象者は人であってよいが、これに限られることなしに、非ヒト動物、実験動物に対しても有効に適用される。
【0013】
そこで以下に実施例を示し、さらに詳しくこの出願の発明について説明する。以下の例においては、ビールを飲む前と飲んだ後のヒト末梢血液にX線、炭素イオン線を照射し、遺伝子障害を染色体異常誘発頻度測定によりビールの防護作用を検討している。もちろん、以下の例によってこの発明が限定されることはない。
【0014】
【実施例】
<実施例1>
ビール700ml(キリンビール)飲酒後採血した血液と飲酒前の血液を、X線(20mA、0.5mmCu+0.5mmAlフィルター、焦点・プローブ間距離55cm)で、またはLET50keV/μmを0〜6Gy照射した。X線で照射した群と炭素イオン線で照射した群の障害の度合いを染色体異常(Dicentric;二動原体染色体)頻度測定することにより飲酒前後の血液で比較し、ビールの電離放射線の生物障害に対する防護作用を調べた。結果は添付図1、図2に示すように細胞1個あたりの平均染色体異常出現頻度を比べると、X線4Gyではビールを飲む前の血液(以下(−)群と略)では1.75、ビールを飲んだ後の血液(以下(+)群と略)では1.23、炭素イオン線4Gyでは(−)群では1.85(+)群では1.23となり、すべての線量において(+)群の値の方が小さかった。このことはX線または炭素イオン線による染色体異常がビールを飲むことにより養生されたことを示すものである。以上の結果より、ビールはヒトのX線または炭素イオン線による障害を防護することが確認された。
<実施例2>
飲酒前の血液とビール700ml(キリンビール)飲酒後30分、1時間、2時間、3時間、4時間、4.5時間で採血した血液をX線(20mA、0.5mmCu+0.5mmAlフィルター、焦点・プローブ間距離55cm)で4Gy照射した。障害の度合いを染色体異常(Dicentric;二動原体染色体)頻度測定することにより飲酒前後の血液で比較し、ビールの電離放射線の生物障害に対する防護作用の効果の持続時間を調べた。
【0015】
その結果を図3に示した。
ビールによる生物障害の防護の有効性が持続可能であることが確認された。
【0016】
【発明の効果】
以上詳しく説明したとおり、この出願の発明によって、電離放射線(高LET放射線を含む)の生物障害を防護または軽減することが可能となる。
【図面の簡単な説明】
【図1】ビール飲酒前後のX線照射における障害の発生結果の例を示した図である。
【図2】ビール飲酒前後の炭素イオン照射線における障害の発生結果の例を示した図である。
【図3】ビール飲酒によるX線に対する防護効果の持続時間を例示した図である。
[0001]
BACKGROUND OF THE INVENTION
The invention of this application relates to an agent for protecting biological damage caused by ionizing radiation such as X-rays, γ-rays, and particle beams, and a protection method using the same.
[0002]
[Prior art and problems of the invention]
It is known that biological damage such as genetic damage or lethality appears when exposed to ionizing radiation, and methods for protecting such biological damage action have been studied from various viewpoints.
[0003]
For example, specifically, with respect to the protection of the biohazardous action of ionizing radiation, protection with lead and protection with drugs have been known so far. Thus, since it is considered that indirect action by radical reaction accounts for about 75% of the cytotoxicity of radiation, radical scavengers have been the main protective agents so far. However, many radical scavengers have been studied as radiation protection agents until now, but they are not practical drugs and are considered to be problematic in terms of safety and effectiveness. In recent years, it has become important to protect against radiation that is mainly direct action due to aircraft and space advancements. In fact, there was no way to protect other than trying to reduce external and internal exposure. In other words, there was no safe policy that could be applied directly to people.
[0004]
The invention of this application was made in view of the circumstances as described above, is highly safe and simple, can protect against biological damage of ionizing radiation for a relatively long time, and It is an object to provide new technical means that can be applied to this.
[0005]
[Means for Solving the Problems]
The invention of this application, as to solve the problem as described above, provides a protective agent of biological damage by carbon ions, characterized in that an active ingredient bi Lumpur.
[0008]
DETAILED DESCRIPTION OF THE INVENTION
The invention of this application has the features as described above, and an embodiment thereof will be described below.
[0009]
Above all, what is characteristic in the invention of this application is that biological damage caused by ionizing radiation is extremely effectively protected by a protective agent containing an alcoholic beverage as an active ingredient.
[0010]
The alcoholic beverage as an active ingredient may be any of well-known alcoholic beverages, brewed liquor, distilled liquor, and mixed liquor, and may be various products including commercial products. These alcoholic beverages are, for example, directly as commercial products or diluted with water or physiological saline, and further added with sugar, various flavors, nutrients, and other drugs. A protective agent can be constructed as an addition.
[0011]
Among them, a more effective protective agent in the invention of this application is an alcoholic beverage containing a component saccharified by malt or koji. In particular, one containing beer components is exemplified as an effective one.
[0012]
The content of alcohol (ethanol) in the alcoholic beverage as an active ingredient is preferably about 2 to 15%.
In actual use, it can be administered orally, and the amount used can be adjusted according to the constitution of the subject, the environment exposed to ionizing radiation, the time required for protection, and the like. Of course, the subject of protection may be a person, but the present invention is not limited to this, and the present invention is effectively applied to non-human animals and laboratory animals.
[0013]
Then, an Example is shown below and invention of this application is demonstrated in detail. In the following example, X-ray and carbon ion rays are irradiated to human peripheral blood before and after drinking beer, and the protective effect of beer is examined by measuring the frequency of chromosomal aberrations for genetic damage. Of course, the present invention is not limited by the following examples.
[0014]
【Example】
<Example 1>
Blood collected after drinking 700 ml of beer (Kirin beer) and blood before drinking were irradiated with X-rays (20 mA, 0.5 mm Cu + 0.5 mm Al filter, focus-probe distance 55 cm), or LET 50 keV / μm at 0 to 6 Gy. Biological disorder of beer ionizing radiation by comparing the degree of damage between the group irradiated with X-rays and the group irradiated with carbon ion radiation in blood before and after drinking by measuring the frequency of chromosomal abnormalities (Dicentric). The protective action against was investigated. As shown in the attached FIG. 1 and FIG. 2, the results show that the average chromosomal abnormality appearance frequency per cell is 1.75 for blood before drinking beer (hereinafter abbreviated as (-) group) in X-ray 4Gy. Blood after drinking beer (hereinafter abbreviated as (+) group) is 1.23, carbon ion beam 4Gy is (-) group is 1.85 (+) group is 1.23, and (+ ) The group value was smaller. This indicates that the chromosomal abnormality caused by X-rays or carbon ion rays was cured by drinking beer. From the above results, it was confirmed that beer protects against damage caused by human X-rays or carbon ion rays.
<Example 2>
Blood before drinking and 700 ml of beer (Kirin beer) 30 minutes after drinking, blood collected at 1 hour, 2 hours, 3 hours, 4 hours, 4.5 hours X-ray (20 mA, 0.5 mm Cu + 0.5 mm Al filter, focus 4Gy irradiation was performed at a distance between probes of 55 cm. The degree of damage was measured by measuring the frequency of chromosomal abnormalities (Dicentric; dicentric chromosomes) in blood before and after drinking, and the duration of the protective effect of beer ionizing radiation on biological damage was investigated.
[0015]
The results are shown in FIG.
It was confirmed that the effectiveness of beer bioprotection was sustainable.
[0016]
【The invention's effect】
As described in detail above, the invention of this application makes it possible to protect or reduce biological damage caused by ionizing radiation (including high LET radiation).
[Brief description of the drawings]
FIG. 1 is a diagram showing an example of a failure occurrence result in X-ray irradiation before and after drinking beer.
FIG. 2 is a diagram showing an example of the result of failure in carbon ion irradiation before and after drinking beer.
FIG. 3 is a diagram illustrating the duration of the protective effect against X-rays caused by drinking beer.

Claims (1)

ビールを有効成分とすることを特徴とする炭素イオン線による生物障害の防護剤。A protective agent for biological damage caused by carbon ion rays , characterized by comprising beer as an active ingredient.
JP2001284016A 2001-09-18 2001-09-18 Protective agent for biological damage caused by ionizing radiation and protection method using the same Expired - Lifetime JP4106430B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001284016A JP4106430B2 (en) 2001-09-18 2001-09-18 Protective agent for biological damage caused by ionizing radiation and protection method using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001284016A JP4106430B2 (en) 2001-09-18 2001-09-18 Protective agent for biological damage caused by ionizing radiation and protection method using the same

Publications (2)

Publication Number Publication Date
JP2003089634A JP2003089634A (en) 2003-03-28
JP4106430B2 true JP4106430B2 (en) 2008-06-25

Family

ID=19107418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001284016A Expired - Lifetime JP4106430B2 (en) 2001-09-18 2001-09-18 Protective agent for biological damage caused by ionizing radiation and protection method using the same

Country Status (1)

Country Link
JP (1) JP4106430B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6992812B2 (en) 2017-08-22 2022-01-13 コニカミノルタ株式会社 Wavelength shift correction system and wavelength shift correction method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6992812B2 (en) 2017-08-22 2022-01-13 コニカミノルタ株式会社 Wavelength shift correction system and wavelength shift correction method

Also Published As

Publication number Publication date
JP2003089634A (en) 2003-03-28

Similar Documents

Publication Publication Date Title
Moulder Post‐irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: a review
Pietrofesa et al. Radiation mitigating properties of the lignan component in flaxseed
Christen‐Clottu et al. Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus)
Chen et al. Ferrostatin-1 obviates seizures and associated cognitive deficits in ferric chloride-induced posttraumatic epilepsy via suppressing ferroptosis
Azmoonfar et al. Mitigation of radiation-induced pneumonitis and lung fibrosis using alpha-lipoic acid and resveratrol
EP2266601A1 (en) Administration of therapeutic viruses
JP6400638B2 (en) Method for preserving protein function and protein storage method
Wang et al. The efficacy and safety of topical β-blockers in treating infantile hemangiomas: a meta-analysis including 11 randomized controlled trials
Cole et al. Age, strain and species factors in post-irradiation protection by spleen homogenates
JP4106430B2 (en) Protective agent for biological damage caused by ionizing radiation and protection method using the same
JP2007176879A (en) Radiation protective agent containing yeast as active ingredient
Muthuraju et al. Effect of normabaric hyperoxia treatment on neuronal damage following fluid percussion injury in the striatum of mice: A morphological approach
CN109152807A (en) Oil palm phenol component for protecting human body, organ, cell and tissue to influence from being exposed to the damaging of ionising radiation
Jadhav et al. Allium cepa L., a potential hepatoprotective and antituberculosis agent
JP4269048B2 (en) Ionizing radiation protective agent
Mante et al. Effect of preirradiation fluoride treatment on the physical properties of dentin
CN114469788A (en) Water-in-oil system high-efficiency sunscreen emulsion and preparation method thereof
US20130039882A1 (en) Method to mitigate injury from radiation exposure
Xianzhe et al. Efficacy of tea polyphenols (TP 50) against radiation-induced hematopoietic and biochemical alterations in beagle dogs.
US20080171097A1 (en) Product liquorice root and oak bark in combination with dexapanthenol
Al Harbi et al. Effectiveness of topical fluoride on dental caries: a literature review
Haley et al. Pharmacology and toxicology of potassium perrhenate and rhenium trichloride
Penchev et al. PROTECTION AGAINST RADIATION-INDUCED TESTICULAR INJURY IN RABBITS BY HABERLEA RHODOPENSIS (A BALKAN RESSURECTION PLANT) EXTRACT.
DE10101543A1 (en) Enhancing the antitumor activity of an amygdalin-containing material, especially loquat kernels, comprises roasting the material with far infrared radiation and fermenting it with microorganisms
Yilmaz et al. Hypericum perforatum L.: A Potent antioxidant source for the treatment of oxidized dentin: An experimental in vitro study

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070724

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070925

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20071120

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080121

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20080124

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080304

R150 Certificate of patent or registration of utility model

Ref document number: 4106430

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term